Skip to main navigation Skip to search Skip to main content

Hybrid benzylidene thiazolidine-2,4-diones as potent apoptosis-inducing anticancer agents: design-driven optimization, cytotoxic profiling, and mechanistic validation in prostate cancer

  • Saad Shaaban*
  • , Samia S. Hawas
  • , Marwa Sharaky
  • , Hussein Ba-Ghazal
  • , Ayman Abo Elmaaty
  • , Khadra B. Alomari
  • , Mohamed Alaasar
  • , Asma M. Elsharif
  • , Fatema S. Alatawi
  • , Mohamed Alaa Mohamed
  • , Arwa Omar Al Khatib
  • , Ahmed A. Al-Karmalawy*
    • *Corresponding author for this work
  • King Faisal University
  • Horus University - Egypt
  • Cairo University
  • Port Said University
  • East Port Said National University
  • Jazan University
  • University of Tabuk
  • Mansoura University
  • Al Ahliyya Amman University
  • University of Mashreq

Research output: Contribution to journal › Article › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Hybrid benzylidene thiazolidine-2,4-diones as potent apoptosis-inducing anticancer agents: design-driven optimization, cytotoxic profiling, and mechanistic validation in prostate cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry